Biofil Chemicals and Pharmaceuticals Ltd

BIOFILCHEM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹96 cr, stock is ranked 2,127
High RiskStock is 3.52x as volatile as Nifty
59.201.05 (+1.81%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹96 cr, stock is ranked 2,127
High RiskStock is 3.52x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
77.07
PB RatioPB Ratio
5.97
Dividend YieldDiv. Yield
Sector PESector PE
32.03
Sector PBSector PB
4.78
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Biofil Chemicals and Pharmaceuticals Limited is engaged in pharmaceuticals and chemicals business. The Company is also engaged in manufacturing plastic products for the purpose of packing of pharmaceutical product and other plastic products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202112.4623.2329.8636.550.470.481.201.25
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Disclosure under SEBI Takeover Regulations 
Announced OnApr 25, 2022

Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 2011 ("SAST Regulations") in respect of disposal of 300000 (Three lacs Only) Equity Shares of Rs. 10/- each (1.84% of the total paid up share capital of the Target Company) through off market by way of gift | Download

Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 2011 ("SAST Regulations") in respect of disposal of 300000 (Three lacs Only) Equity Shares of Rs. 10/- each (1.84% of the total paid up share capital of the Target Company) through off market by way of gift | Download

Disclosure under SEBI Takeover Regulations 
Announced OnApr 25, 2022

Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 2011 ("SAST Regulations") in respect of acquisition of 300000 (Three Lacs Only) Equity Shares of Rs. 10/- each (1.84% of the total paid up share capital of the Target Company) through Off market by way of gift | Download

Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 2011 ("SAST Regulations") in respect of acquisition of 300000 (Three Lacs Only) Equity Shares of Rs. 10/- each (1.84% of the total paid up share capital of the Target Company) through Off market by way of gift | Download

Disclosure under SEBI Takeover Regulations 
Announced OnApr 9, 2022

Promoter/Promoter Group of Biofil Chemicals & Pharmaceuticals Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 | Download

Promoter/Promoter Group of Biofil Chemicals & Pharmaceuticals Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 | Download

See all events